BEVALTIA Trademark

Trademark Overview


On Wednesday, January 18, 2023, a trademark application was filed for BEVALTIA with the United States Patent and Trademark Office. The USPTO has given the BEVALTIA trademark a serial number of 97758949. The federal status of this trademark filing is REGISTERED as of Tuesday, October 24, 2023. This trademark is owned by Roivant Sciences GmbH. The BEVALTIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations to treat Crohn's Disease for human use; biologic preparations for medical and therapeutic purposes to treat Chron's disease, inflammatory diseases and disorders, diseases and disorders of the immune system, dermatomyositis, systemic lupus erythematosus (SLE), hidradenitis suppurativa, scleroderma, sarcoidosis, juvenile dermatomyositis, and non-infectious uveitis; pharmaceutical preparations to treat inflammatory diseases and disorders and diseases and disorders of the immune system; pharmaceutical preparations to treat dermatomyositis, systemic lupus erythematosus (SLE), hidradenitis suppurativa, scleroderma, sarcoidosis, juvenile dermatomyositis, and non-infectious uveitis
bevaltia

General Information


Serial Number97758949
Word MarkBEVALTIA
Filing DateWednesday, January 18, 2023
Status700 - REGISTERED
Status DateTuesday, October 24, 2023
Registration Number7202066
Registration DateTuesday, October 24, 2023
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 8, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations to treat Crohn's Disease for human use; biologic preparations for medical and therapeutic purposes to treat Chron's disease, inflammatory diseases and disorders, diseases and disorders of the immune system, dermatomyositis, systemic lupus erythematosus (SLE), hidradenitis suppurativa, scleroderma, sarcoidosis, juvenile dermatomyositis, and non-infectious uveitis; pharmaceutical preparations to treat inflammatory diseases and disorders and diseases and disorders of the immune system; pharmaceutical preparations to treat dermatomyositis, systemic lupus erythematosus (SLE), hidradenitis suppurativa, scleroderma, sarcoidosis, juvenile dermatomyositis, and non-infectious uveitis

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 24, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePRIOVANT THERAPEUTICS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressNEW YORK, NY 10036

Party NameRoivant Sciences GmbH
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBasel 4051
CH

Party NameRoivant Sciences GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBasel 4051
CH

Party NameRoivant Sciences GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBasel 4051
CH

Trademark Events


Event DateEvent Description
Wednesday, May 31, 2023ASSIGNED TO EXAMINER
Saturday, January 21, 2023NEW APPLICATION ENTERED
Tuesday, January 24, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 29, 2023EXAMINERS AMENDMENT E-MAILED
Thursday, June 29, 2023EXAMINERS AMENDMENT -WRITTEN
Thursday, June 29, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, June 29, 2023EXAMINER'S AMENDMENT ENTERED
Friday, June 30, 2023ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Thursday, June 29, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 6, 2023ELECTRONIC RECORD REVIEW COMPLETE
Tuesday, August 8, 2023PUBLISHED FOR OPPOSITION
Wednesday, July 19, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 8, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 24, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, October 24, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Friday, March 1, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, March 1, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 1, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 1, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 1, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP